GigaPath-Flash and GigaTIME-Flash, efficient models for whole-slide pathology AI and spatial proteomics prediction, are introduced and all models and weights are released, providing accessible building blocks for computational pathology, immuno-oncology, and precision health.
Abstract
Foundation models have emerged as a driving force in computational pathology, with the potential to transform cancer diagnosis, prognosis, and treatment selection by learning transferable representations from large-scale histopathology data. A growing landscape of pathology foundation models now spans diverse data sources, architectures, and downstream applications. However, most pretrained models operate only at the image-tile level, use restrictive licenses, and remain computationally expensive, limiting large-scale slide-level clinical and research use. Here, we introduce GigaPath-Flash and GigaTIME-Flash, efficient models for whole-slide pathology AI and spatial proteomics prediction. GigaPath-Flash combines a 22M-parameter ViT-S tile encoder with a 21M-parameter LongNet slide encoder, both pretrained on large-scale real-world histopathology data. Its compact tile encoder is distilled from the billion-parameter GigaPath (ViT-g) teacher and shared by both models. GigaPath-Flash retains 97% of GigaPath's average slide-level performance with 50x less compute. GigaTIME-Flash extends this backbone to predict the tumor immune microenvironment directly from routine H&E images. It surpasses the original CNN-based GigaTIME in prediction quality while running 6x faster and using 8x less GPU memory. Together with GigaPath and GigaTIME, these models form an open-weight, Apache-2.0-licensed family pretrained on large-scale real-world clinical data. By releasing all models and weights, we provide accessible building blocks for computational pathology, immuno-oncology, and precision health.
Multi-Resolution Pyramid Transformer (MRPT) is introduced, a model that hierarchically aggregates multi-resolution information from cellular to tissue and WSI levels and surpasses recent foundation models and Multimodal Large Language Models in cancer subtype classification, tissue phenotyping, and Visual Question Answ...
B. Alawode, Moshira Abdalla, Dwarikanath Mahapatra et al.· 0 citations
Thirty pathology-specific and general-purpose foundation models are benchmarked through 304,920 runs across spatial readouts, magnifications, taxonomic granularities, and evaluation protocols, yielding distinct multidimensional capability profiles.
Bo-Kai Zhao, Yi-Yang Zhang, Hanqing Chao et al.· 0 citations
SLICEChat is introduced, a slide-level MLLM that integrates progressive token pruning within a hybrid Mamba--Transformer slide encoder, which demonstrates accurate and computationally efficient multimodal reasoning over gigapixel WSIs.
Ali Kerem Bozkurt, Baris Cem Bakay, Ibrahim Kulac et al.· 0 citations
DistillPath-KS16 is presented, which starts from the existing 22M kaiko ViT-S/16 encoder and improves it by distilling from released pathology encoders used as frozen teachers, needing neither their DINO nor iBOT pretraining heads nor a billion-tile corpus.
Ramon Kaspar, Andrey Ignatov, Valentina Boeva· 2 citations
Foundation models trained on large pathology image corpora now provide strong, transferable representations for computational pathology. Over the past few years a series of such models has been released, each trained on more slides than the last; on standard classification and segmentation benchmarks, the leading model...
Zhi Li, E. Amidi, Ya-Ting Cheng et al.· 0 citations
Whole-slide imaging offers a route to scalable computational assessment of colorectal histology, but models developed on public cohorts may not transfer reliably to real-world clinical practice. We developed V7-DiVA (Version 7 Deep Integrated Visual Analytics), a feature-based, gated-attention deep multiple-instance le...
Mingchen Sun, Wencong Kong, Shuanglong Qiu et al.· Journal of Translational Med...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.